Uruguay

Reimbursed Care Access

Uruguay maintains a conventional controlled‑substances approach to classic and novel psychedelics: most classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca) are treated under national drug control schemes with no routine reimbursed medical programs; ketamine is an accepted medical/veterinary anesthetic and is used off‑label in some private clinical settings for psychiatric indications. There is active public debate, some private/‘grey‑area’ practice and interest from clinicians/entrepreneurs, but no broad public insurance reimbursement framework for psychedelic‑assisted therapies as of the searches performed for this report.